Discover 1,272 paid clinical trials in Mesa, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,272
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Mesa AZ, Las Vegas NV, Loma Linda CA, El Paso TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Mesa AZ, Chandler AZ, Gilbert AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase3, Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
for
Metastatic Castration-Resistant Prostate Cancer
Location: Mesa AZ, Chandler AZ, Gilbert AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT06629779
Phase3, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Mesa AZ, Chandler AZ, Gilbert AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase3, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Mesa AZ, Chandler AZ, Gilbert AZ, Scottsdale AZ,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Location: Mesa AZ, Glendale AZ, San Diego CA, Tarzana CA,
Sponsor: Olatec Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05658575
Phase2, Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: Mesa AZ, Glendale AZ, Albuquerque NM, Oklahoma City OK,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06807424
Phase3, Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
for
Psoriatic Arthritis
Location: Mesa AZ, Phoenix AZ, Tucson AZ, Covina CA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06671496
Phase3, Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for
Gout
Location: Mesa AZ, Gilbert AZ, Glendale AZ, Tucson AZ,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089875
Phase3, Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for
Tophaceous Gout
Location: Mesa AZ, Gilbert AZ, Glendale AZ, Tucson AZ,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089888
Phase3, Recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
for
Diffuse Cutaneous Systemic Sclerosis
Location: Mesa AZ, Newport Beach CA, Los Angeles CA, Allen TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70
Code: NCT06470048
Phase2, Recruiting
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Mesa AZ, Tucson AZ, Vista CA, Los Angeles CA, Fresno CA,
Sponsor: Piomic Medical
Sex: All
Age: 22 - 70+
Code: NCT05758545
Recruiting
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
for
Chronic Diabetic Foot Ulcers
Location: Phoenix AZ, Los Angeles CA, Tulsa OK, Opelousas LA,
Sponsor: SerenaGroup, Inc.
Sex: All
Age: 18+
Code: NCT04457752
Recruiting
Open Versus Arthroscopic Stabilization of Shoulder Instability With Subcritical Bone Loss: The OASIS Trial
for
Shoulder Dislocation, Glenohumeral Dislocation,
Location: Tempe AZ, Fort Sam Houston TX, Nashville TN,
Sponsor: University of Pittsburgh
Sex: All
Age: 17 - 50
Code: NCT04809064
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Tempe AZ, Phoenix AZ, Scottsdale AZ, North Las Vegas NV,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for
Non-small Cell Lung Cancer,
Location: Gilbert AZ, Newport Beach CA, Duarte CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05877599
Phase1, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Gilbert AZ, Chandler AZ, Goodyear AZ, San Diego CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Gilbert AZ, Phoenix AZ, Goodyear AZ, San Diego CA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Gilbert AZ, Phoenix AZ, San Diego CA, Albuquerque NM,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Gilbert AZ, Newport Beach CA, Fountain Valley CA,